A randomised, double-blind, placebo controlled multi-centre trial of combination therapy with methotrexate plus cyclosporin vs methotrexate plus placebo in patients with active psoriatic arthritis (PsA).

被引：0
|
作者：
Fraser, AD
van Kuryk, A
Westhovens, R
Karim, Z
Gerards, A
Landewe, RBM
Steinfeld, S
Emery, P
Dijkmans, BAC
Veale, DJ
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] VU Univ Med Ctr, Amsterdam, Netherlands
[3] Univ Leuven, Louvain, Belgium
[4] Univ Hosp Maastricht, Maastricht, Netherlands
[5] Erasme Univ Hosp, B-1070 Brussels, Belgium
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
344
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [21] GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
    Vieira-Sousa, Elsa
    Alves, Pedro
    Rodrigues, Ana M.
    Teixeira, Filipa
    Tavares-Costa, Jose
    Bernardo, Alexandra
    Pimenta, Sofia
    Pimentel-Santos, Fernando M.
    Gomes, Joao Lagoas
    Aguiar, Renata
    Pinto, Patricia
    Videira, Taciana
    Catita, Cristina
    Santos, Helena
    Borges, Joana
    Sequeira, Graca
    Ribeiro, Celia
    Teixeira, Lidia
    Avila-Ribeiro, Pedro
    Martins, Fernando M.
    Canhao, Helena
    McInnes, Iain B.
    Ribeiro, Ruy M.
    Fonseca, Joao Eurico
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (04) : 490 - 498
  • [22] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
    S H Lim
    T W Kim
    Y S Hong
    S-W Han
    K-H Lee
    H J Kang
    I G Hwang
    J Y Lee
    H S Kim
    S T Kim
    J Lee
    J O Park
    S H Park
    Y S Park
    H Y Lim
    S-H Jung
    W K Kang
    British Journal of Cancer, 2015, 113 : 1421 - 1426
  • [23] A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
    Lim, S. H.
    Kim, T. W.
    Hong, Y. S.
    Han, S-W
    Lee, K-H
    Kang, H. J.
    Hwang, I. G.
    Lee, J. Y.
    Kim, H. S.
    Kim, S. T.
    Lee, J.
    Park, J. O.
    Park, S. H.
    Park, Y. S.
    Lim, H. Y.
    Jung, S-H
    Kang, W. K.
    BRITISH JOURNAL OF CANCER, 2015, 113 (10) : 1421 - 1426
  • [24] RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF LOW-DOSE PULSE METHOTREXATE IN PSORIATIC-ARTHRITIS
    WILLKENS, RF
    WILLIAMS, HJ
    WARD, JR
    EGGER, MJ
    READING, JC
    CLEMENTS, PJ
    CATHCART, ES
    SAMUELSON, CO
    SOLSKY, MA
    KAPLAN, SB
    GUTTADAURIA, M
    HALLA, JT
    WEINSTEIN, A
    ARTHRITIS AND RHEUMATISM, 1984, 27 (04): : 376 - 381
  • [25] A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study
    Lan, JL
    Chou, SJ
    Chen, DY
    Chen, YH
    Hsieh, TY
    Young, M
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (08) : 618 - 623
  • [26] Treatment of patients with undifferentiated arthritis with methotrexate: A double-blind placebo-controlled randomized clinical trial
    van Dongen, H.
    van Aken, J.
    Lard, L. R.
    Ronday, H. K.
    Speyer, I.
    Westedt, M. L.
    Allaart, C. F.
    Breedveld, F. C.
    Huizinga, T. W. J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 16 - 16
  • [27] Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial
    Hara, Masako
    Ishiguro, Naoki
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Yamamoto, Kazuhiko
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 410 - 418
  • [28] Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
    Rangaka, Molebogeng X.
    Wilkinson, Robert J.
    Boulle, Andrew
    Glynn, Judith R.
    Fielding, Katherine
    van Cutsem, Gilles
    Wilkinson, Katalin A.
    Goliath, Rene
    Mathee, Shaheed
    Goemaere, Eric
    Maartens, Gary
    LANCET, 2014, 384 (9944): : 682 - 690
  • [29] Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Hara, Masako
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 430 - 439
  • [30] Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate - A randomized, double-blind, placebo-controlled trial
    Kremer, JM
    Genovese, MC
    Cannon, GW
    Caldwell, JR
    Cush, JJ
    Furst, DE
    Luggen, ME
    Keystone, E
    Weisman, MH
    Bensen, WM
    Kaine, JL
    Ruderman, EM
    Coleman, P
    Curtis, DL
    Kopp, EJ
    Kantor, SM
    Waltuck, J
    Lindsley, HB
    Markenson, JA
    Strand, V
    Crawford, B
    Fernando, I
    Simpson, K
    Bathon, JM
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (09) : 726 - 733
12345